Evidence map›Paper›PMID 37055196›Full record

ArticleGenome research2023

Inferring the mode and strength of ongoing selection.

Gustavo V Barroso, Kirk E Lohmueller

Abstract read
In one paragraph

Article in Genome research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Revisiting Dominance in Population Genetics.Genome biology and evolution · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gustavo V BarrosoDepartment of Ecology and Evolutionary Biology, University of California, Los Angeles, California 90095-1606, USA; Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, California 90095, USA gvbarroso@gmail.com klohmueller@ucla.edu.ORCID 0000-0002-1943-9297
Kirk E LohmuellerDepartment of Ecology and Evolutionary Biology, University of California, Los Angeles, California 90095-1606, USA; Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, California 90095, USA gvbarroso@gmail.com klohmueller@ucla.edu.ORCID 0000-0002-3874-369X

Funding

Population genomics of the selective effects of new mutationsR35GM119856 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LOHMUELLER, KIRK · 2016 to 2025
$3.4M
NIGMS NIH HHS R35 GM119856
6 · The paper itself

Abstract

Genome sequence data are no longer scarce. The UK Biobank alone comprises 200,000 individual genomes, with more on the way, leading the field of human genetics toward sequencing entire populations. Within the next decades, other model organisms will follow suit, especially domesticated species such as crops and livestock. Having sequences from most individuals in a population will present new challenges for using these data to improve health and agriculture in the pursuit of a sustainable future. Existing population genetic methods are designed to model hundreds of randomly sampled sequences but are not optimized for extracting the information contained in the larger and richer data sets that are beginning to emerge, with thousands of closely related individuals. Here we develop a new method called trio-based inference of dominance and selection (TIDES) that uses data from tens of thousands of family trios to make inferences about natural selection acting in a single generation. TIDES further improves on the state of the art by making no assumptions regarding demography, linkage, or dominance. We discuss how our method paves the way for studying natural selection from new angles.

Indexed as

GenomeSelection, GeneticGenetics, PopulationHumansLongitudinal Studies

Identifiers

PMID37055196
PMCPMC10234300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.